Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-003109 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
71,550
Total Value
$614,974.40
P&L
+inf% (+$761,371.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Exercise/Conversion | 16,000 | $3.33 | $53,280.00 | 148,036 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Sale | 16,000 | $35.11 | $561,694.40 | 132,036 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Grant/Award | 3,150 | $0.00 | $0.00 | 135,186 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 16,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 20,400 | $0.00 | $0.00 | 20,400 | Direct | โ | View Details |